The use of lorazepam for treatment of pediatric status epilepticus

劳拉西泮在治疗小儿癫痫持续状态中的应用

• 批准号: 8332557
• 负责人: JIM CHAMBERLAIN
• 金额: $ 209.15万
• 依托单位: CHILDREN'S RESEARCH INSTITUTE
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-09-09 至 2013-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8332557
• 关键词: Age; Childhood; Clinical Data; Contractor; Double-Blind Method; Drug Kinetics; Drug usage; FDA approved; Goals; Inpatients; Label; Lead; Lorazepam; Patients; Population; Randomized; Safety; Status Epilepticus; active control

The goal of this study is to obtain sufficient clinical data on the use of lorazapam for treatment of status epilepticus in pediatric populations, which will lead to FDA-approved labeling of lorazapam for this purpose.

本研究的目的是获得关于使用劳拉西泮治疗儿科人群癫痫持续状态的充分临床数据，这将导致FDA批准劳拉西泮用于此目的的标签。